Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-27

FDA Approved: SUPRANE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for SUPRANE (desflurane) by Baxter Healthcare Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUPRANE (DESFLURANE)

Snippet

SUPPL AP for SUPRANE (DESFLURANE)